Population
Patients with systolic heart failure (left ventricular systolic dysfunction)
Design
Review
Authors
Loading...
May inform non-specialist systolic HF care with RAAS agents; leaves open optimal sequencing of emerging therapies.
This review provides practical guidance for non-specialists on the use of current and emerging RAAS blockade agents in the management of systolic heart failure.
Orsborne et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: